Imatinib in Adult Patients With Metastatic Ocular Melanoma (O-Mel-Inib)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00421317
Recruitment Status : Terminated (Study stopped at the end of the first step)
First Posted : January 11, 2007
Last Update Posted : January 6, 2016
National Cancer Institute, France
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2007
  Study Completion Date : March 2007